Synthesis and Preclinical Evaluation of <sup>18</sup>F-Labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35332095.
- Also identified by DOI 10.2967/jnumed.121.263713 and PMC identifier 9635687.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cyclooxygenase (COX) is a rate-limiting enzyme in the synthesis of proinflammatory prostanoids from arachidonic acid. In vivo imaging of COX by PET is a potentially powerful tool for assessing the inflammatory response to injury, infection, and disease. We previously reported on a promising PET probe for COX imaging, <sup>11</sup>C-labeled ketoprofen methyl ester, which can detect COX-1 activation in models of neuroinflammation and neurodegenerative disorders. In the current study, we aimed to design a fluorine-substituted benzoyl group of ketoprofen (FKTP) and to evaluate its racemate and enantiomers (<sup>18</sup>F-labeled ketoprofen methyl ester, [<sup>18</sup>F]FKTP-Me) as PET proradiotracers, potential radiopharmaceuticals for in vivo PET study of COX-1. <b>Methods:</b> We performed nucleophilic aromatic <sup>18</sup>F-fluorination to obtain the desired racemic radiolabeled probe, (<i>RS</i>)-[<sup>18</sup>F]FKTP-Me, at a radiochemical yield of 11%-13%. Subsequent high-performance liquid chromatography separation with a chiral column yielded the desired enantiomerically pure (<i>R</i>)- and (<i>S</i>)-[<sup>18</sup>F]FKTP-Me. We examined the in vivo properties of (<i>RS</i>)-, (<i>R</i>)-, and (<i>S</i>)-[<sup>18</sup>F]FKTP-Me in PET studies using rats in which hemispheric inflammation was induced by intrastriatally injecting a lipopolysaccharide. <b>Results:</b> Racemic (<i>RS</i>)-[<sup>18</sup>F]FKTP-Me and enantiomeric (<i>R</i>)- or (<i>S</i>)-[<sup>18</sup>F]FKTP-Me were synthesized with radiochemical and chemical purities of more than 99%. The metabolite analysis revealed that the racemic (<i>RS</i>)-[<sup>18</sup>F]FKTP-Me crossed the blood-brain barrier and entered the brain, where it was subsequently hydrolyzed to its pharmacologically active acid form. PET images revealed a high accumulation of (<i>R</i>)-, (<i>S</i>)-, and (<i>RS</i>)-[<sup>18</sup>F]FKTP in the inflamed regions in rat brain. Moreover, the accumulated radioactivity of (<i>S</i>)-[<sup>18</sup>F]FKTP-Me was higher than that of (<i>RS</i>)-[<sup>18</sup>F]FKTP-Me and (<i>R</i>)-[<sup>18</sup>F]FKTP-Me, which was correlated with the stereospecific inhibitory activity of FKTP against COX-1. <b>Conclusion:</b> From the results of this study, we conclude that racemic (<i>RS</i>)-[<sup>18</sup>F]FKTP-Me and its enantiomers could act as proradiotracers of neuroinflammation in rat brain by the association of their hydrolyzed acid forms with COX-1 in inflamed regions. In particular, (<i>S</i>)-[<sup>18</sup>F]FKTP-Me demonstrated suitable properties as a COX-1-specific probe in PET imaging of neuroinflammation.
Medical subject headings
- Cyclooxygenase 1
- Ketoprofen